# Washington University Institute of Clinical Translational Sciences

> **NIH NIH UL1** · WASHINGTON UNIVERSITY · 2020 · $9,359,641

## Abstract

The Washington University (WU) Institute of Clinical and Translational Sciences (ICTS) has transformed
clinical and translational science and research education in our region, and fostered productive scientific
collaborations with our hub partner institutions University of Missouri-Columbia, Saint Louis University, St.
Louis College of Pharmacy, BJC HealthCare, Barnes Jewish Hospital, and St. Louis Children's Hospital. The
ICTS now proposes innovative aims that align well with the goals of the CTSA network, and will together
catalyze discovery and advance research findings into real-world implementation to improve health and health
care.
1. Provide interdisciplinary programs to develop, promote, and retain highly qualified and diverse
faculty, trainees, and staff who can translate scientific discoveries into action. We will tailor our efforts to
the needs of individuals, promote formation of transdisciplinary, inter-institutional, and inter-hub teams,
rigorously assess our programs, and draw on our institutional and regional strengths in genomics,
dissemination and implementation, and entrepreneurship. WORKFORCE DEVELOPMENT
2. Facilitate research that is designed for implementation by engaging diverse communities and
stakeholders in collaborative teams at all stages of the translational research process. We will partner
with patient advocates, propel the science of community and stakeholder engagement, break down barriers to
allow integration of research findings into clinical practice, and capitalize on our local entrepreneurial
ecosystem to apply discoveries to improve community health. COLLABORATION AND ENGAGEMENT
3. Integrate research across the lifespan and promote translational science within complex
populations. The ICTS will address health disparities and differences in disease manifestations across
different ages and among special populations, address both urban and rural populations, catalyze formation of
transdisciplinary teams, and evaluate the clinical, community, and entrepreneurial outcomes of our
researchers' work. INTEGRATION
4. Drive innovation, quality, and efficiency in the translational research, by using best practices and
streamlined institutional processes to support high quality multi-center clinical trials and developing new
methodological approaches to facilitate translational research. METHODS AND PROCESSES
5. Apply innovative informatics solutions to improve quality and efficiency at every stage of
translational research, and create an ecosystem that integrates diverse data and facilitates the
interoperability, use, and reuse of digital assets. INFORMATICS
Successful completion of these aims will transform regional research, dissemination, and workforce
development and will apply the considerable resources of WU and its partners to national CTSA goals to
advance clinical and translational science and improve human health.

## Key facts

- **NIH application ID:** 9889200
- **Project number:** 5UL1TR002345-04
- **Recipient organization:** WASHINGTON UNIVERSITY
- **Principal Investigator:** William G. Powderly
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $9,359,641
- **Award type:** 5
- **Project period:** 2017-06-19 → 2022-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9889200

## Citation

> US National Institutes of Health, RePORTER application 9889200, Washington University Institute of Clinical Translational Sciences (5UL1TR002345-04). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9889200. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*